Rafael Nadal lost 6-4, 6-4 to Botic van de Zandschulp in the Davis Cup on Tuesday in what may have been the last match of the Spaniard's career.

This award recognizes Padia’s creative vision to develop the HealthEquity Immersion Experience — a project that showcases HealthEquity’s deep understanding of the client and member benefits journey ...

HQY is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of A and VGM Score of B. Earnings are expected to grow 37.3% ...

HealthEquity (HQY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Atria Investments Inc cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 19.5% in the 3rd quarter, ...

Oct. 31, 2024 — A research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an ... Kidney Transplantation ...

Fintel reports that on November 15, 2024, Goldman Sachs initiated coverage of HealthEquity (NasdaqGS:HQY) with a Neutral ...

Goldman Sachs initiates buy rating on Teladoc Health with $14 price target, while assigning neutral ratings on Doximity and HealthEquity. Read more here.

Wolfe Research analyst Alexandria Hammond initiated coverage on Johnson & Johnson JNJ with an Outperform rating and announced ...

Progyny (PGNY) stock plunged 18% Wednesday after the fertility benefits manager lowered its 2024 guidance, prompting Truist ...

8 analysts have expressed a variety of opinions on HealthEquity HQY over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of ...

Barclays analyst Stephanie Davis maintained a Buy rating on Healthequity (HQY – Research Report) today and set a price target of $104.00. The company’s shares closed yesterday at $100.20. Davis covers ...